Lone L. Hansen

491 total citations
9 papers, 372 citations indexed

About

Lone L. Hansen is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Lone L. Hansen has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in Lone L. Hansen's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer therapeutics and mechanisms (2 papers). Lone L. Hansen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer therapeutics and mechanisms (2 papers). Lone L. Hansen collaborates with scholars based in Denmark, Sweden and Israel. Lone L. Hansen's co-authors include Kim Brøsen, Anna K. Busch, Yukio Ikeda, Grith Skytte Olsen, Per Damkier, Luitgard Mosthaf, John Larsen, Ehud Ziv, Bo F. Hansen and Eleazar Shafrir and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and British Journal of Clinical Pharmacology.

In The Last Decade

Lone L. Hansen

9 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lone L. Hansen Denmark 8 136 103 102 57 49 9 372
Jeffrey A. Handler United States 13 186 1.4× 46 0.4× 92 0.9× 52 0.9× 39 0.8× 22 422
Heike Hellmold Sweden 13 246 1.8× 53 0.5× 173 1.7× 74 1.3× 26 0.5× 19 618
Y Sakai Japan 8 124 0.9× 129 1.3× 131 1.3× 55 1.0× 52 1.1× 12 516
J L Ferrero United States 9 96 0.7× 115 1.1× 146 1.4× 69 1.2× 24 0.5× 11 434
Su-Er W. Huskey United States 11 133 1.0× 50 0.5× 194 1.9× 127 2.2× 59 1.2× 13 548
Michele Bortolini Switzerland 10 196 1.4× 75 0.7× 181 1.8× 112 2.0× 77 1.6× 10 644
Juan A. Monti Argentina 14 206 1.5× 67 0.7× 93 0.9× 88 1.5× 101 2.1× 36 637
Karen Richards United States 8 284 2.1× 101 1.0× 107 1.0× 88 1.5× 68 1.4× 13 477
Chiyuki Yamato Japan 14 157 1.2× 57 0.6× 106 1.0× 79 1.4× 34 0.7× 34 522
Byung Joon Song United States 6 130 1.0× 56 0.5× 233 2.3× 92 1.6× 36 0.7× 11 448

Countries citing papers authored by Lone L. Hansen

Since Specialization
Citations

This map shows the geographic impact of Lone L. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lone L. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lone L. Hansen more than expected).

Fields of papers citing papers by Lone L. Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lone L. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lone L. Hansen. The network helps show where Lone L. Hansen may publish in the future.

Co-authorship network of co-authors of Lone L. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lone L. Hansen. A scholar is included among the top collaborators of Lone L. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lone L. Hansen. Lone L. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hansen, Lone L.. (2007). Merger, Moving and Division Across National Borders – When Case Law Breaks through Barriers and Overtakes Directives. European Business Law Review. 18(Issue 1). 181–204. 6 indexed citations
2.
Ikeda, Yukio, Grith Skytte Olsen, Ehud Ziv, et al.. (2001). Cellular Mechanism of Nutritionally Induced Insulin Resistance in Psammomys Obesus. Diabetes. 50(3). 584–592. 73 indexed citations
3.
Hansen, Lone L. & Kim Brøsen. (1999). Quantitative Determination of Tolbutamide and Its Metabolites in Human Plasma and Urine by High-Performance Liquid Chromatography and UV Detection. Therapeutic Drug Monitoring. 21(6). 664–664. 18 indexed citations
4.
Damkier, Per, Lone L. Hansen, & Kim Brøsen. (1999). Rifampicin Treatment Greatly Increases the Apparent Oral Clearance of Qninidine. Pharmacology & Toxicology. 85(s2). 257–262. 21 indexed citations
5.
Hansen, Lone L., Yukio Ikeda, Grith Skytte Olsen, Anna K. Busch, & Luitgard Mosthaf. (1999). Insulin Signaling Is Inhibited by Micromolar Concentrations of H2O2. Journal of Biological Chemistry. 274(35). 25078–25084. 146 indexed citations
6.
Damkier, Per, Lone L. Hansen, & Kim Brøsen. (1999). Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine. British Journal of Clinical Pharmacology. 48(6). 829–838. 47 indexed citations
7.
Larsen, John, Lone L. Hansen, Olav Spigset, & Kim Brøsen. (1999). Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo. European Journal of Clinical Pharmacology. 55(5). 375–382. 19 indexed citations
8.
Damkier, Per, Lone L. Hansen, & Kim Brøsen. (1999). Effect of fluvoxamine on the pharmacokinetics of quinidine. European Journal of Clinical Pharmacology. 55(6). 451–456. 24 indexed citations
9.
Hansen, Lone L., John Larsen, & Kim Brøsen. (1998). Determination of tacrine and its metabolites in human plasma and urine by high-performance liquid chromatography and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 712(1-2). 183–191. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026